Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study-Reference-Cited by-同舟云学术

Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study

Published:2020-10-10 Issue:1 Volume:96 Page:51-59
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Schep Sarah J.¹^ORCID,Dijk Wobke E. M.¹,Beckers Erik A. M.²,Meijer Karina³,Coppens Michiel⁴,Eikenboom Jeroen⁵,Leebeek Frank W. G.⁶,Vulpen Lize F. D.¹,Fischer Kathelijn F.¹,Schutgens Roger E. G.¹,

Affiliation:

1. Van Creveldkliniek University Medical Center Utrecht, University Utrecht Utrecht The Netherlands

2. Department of Internal Medicine/Hematology Maastricht University Medical Center +, part of the Nijmegen/Eindhoven/Maastricht Haemophilia Treatment Center (HTC) Maastricht The Netherlands

3. Department of Hematology University Medical Center Groningen, University of Groningen Groningen The Netherlands

4. Department of Vascular Medicine Amsterdam University Medical Centers, University of Amsterdam Amsterdam The Netherlands

5. Division of Thrombosis and Hemostasis, Department of Internal Medicine Leiden University Medical Center, part of the Leiden/The Hague HTC Leiden The Netherlands

6. Department of Hematology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26009

Reference21 articles.

1. Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy

2. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

3. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry

4. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation

5. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line immunosuppressive therapies for acquired hemophilia A: A 25-year cohort experience and network meta-analysis;Thrombosis Research;2024-09

2. Hémophilie acquise : quoi de neuf en 2024 ?;La Revue de Médecine Interne;2024-09

3. Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes;Haemophilia;2024-06-28

4. Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A;Journal of Thrombosis and Haemostasis;2024-06

5. Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol;Pathology and Oncology Research;2024-05-23